USPTO serial 79413408
TRASIS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 2, 2026
- Examiner
- MASON, JARED MICHAEL
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TRASIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kimberly N. Fisher
Kimberly N. Fisher Kolitch Romano Dascenzo Gates LLC621 SW Morrison Street #1100Portland, OR 97205United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Scientific, optical, weighing, measuring, checking apparatus and instruments for conducting quality controls in pharmaceutical chemistry, radiopharmacy and nuclear medicine, namely, integrated quality control devices for streamlining and automating the quality control of positron emission tomography tracers; apparatus and instruments for the production, distribution, manipulation and analysis not for medical use of chemical and pharmaceutical products and radioactive materials, namely, automated devices for the radiochemical synthesis of positron emission tomography and single-photon emission computerized tomography tracers, and mechanical devices, namely, dispensers of preset portions of fluids, solid granules and powder for dosing purposes, all not for medical use; radioprotection devices, namely, hot cells for handling radioactive materials safely, shielded screen and shielded containers for handling radioactive materials safely; scientific apparatus and instruments for synthesizing chemical products not for medical use, namely, automated devices for the radiochemical synthesis of positron emission tomography and single-photon emission computerized tomography tracers; scientific apparatus and instruments for the treatment of radioactive materials not for medical use, namely, automated devices for the radiochemical synthesis of positron emission tomography and single-photon emission computerized tomography tracers and mechanical devices, namely, dispensers of preset portions of fluids, solid granules and powder for dosing purposes, all not for medical use; dosimeters; downloadable computer software for a centralized control software platform designed to control and monitor all automated systems involved in the production and quality control of radiopharmaceuticals; downloadable computer software for analyzing, viewing and transmitting medical data | ACTIVE | — |
| 010 | Apparatus and instruments for the production, distribution, manipulation and analysis for medical use of chemical and pharmaceutical products and radioactive materials, namely, automated devices for the radiochemical synthesis of positron emission tomography and single-photon emission computerized tomography tracers, dosage dispensers for administering medicine to patients, integrated quality control devices for streamlining and automating the quality control of positron emission tomography tracers; apparatus and instruments for synthesizing chemical products for medical use, namely, automated devices for the radiochemical synthesis of positron emission tomography and single-photon emission computerized tomography tracers; apparatus and instruments for the treatment of radioactive materials for medical use, namely, automated devices for the radiochemical synthesis of positron emission tomography and single-photon emission computerized tomography tracers and dosage dispensers for administering medicine to patients; apparatus for the administration of medicines, namely, drug delivery catheters and dosage dispensers for administering medicine to patients; automatic medical apparatus for dose injection for humans in particular medical syringes and medical fluid injectors; metering pumps for administering medicines in measured quantities for medical use; infusion pumps for administering medicines; intravenous infusion pumps for medical use; dosage dispensers for medical use, namely, dosage dispensers for administering medicine to patients; apparatus for administering medical fluids for the administration of radiopharmaceuticals and disposable medical syringes for use therewith; apparatus in the nature of infusion pumps for administering contrast agents for medical use; infusion lines being infusion devices for administering drugs; infusion columns being infusion devices for administering drugs; hypodermic needles for infusion therapy; medical syringes; multishot needle medical syringes; syringe needles for medical use; disposable medical needles for hypodermic syringes; syringe pushers for medical use; valves being component replacement parts for medical infusion instruments for administering drugs; catheters; tubes being parts for catheters; protectors being parts specially adapted for catheters; transfusion medical tubing; intravenous feeding tubes; tubing for medical transfusion use; medical instruments for therapeutic monitoring of medicinal treatments; sensors for medical use for monitoring patients' vital signs; structures for protection against radiation for medical use, namely, patient x-ray radiation shields | ACTIVE | — |
| 037 | Maintenance, adjustment being repair and repair of medical apparatus and instruments, in particular apparatus for administering drugs and fluids for medical use | ACTIVE | — |
| 042 | Scientific and technological services as well as research and design services relating thereto, namely, scientific research in the fields of radiopharmacy, production, distribution, handling and analysis of chemicals and pharmaceuticals and radioactive materials; scientific research in the fields of radiopharmacy, production, distribution, handling and analysis of chemical and pharmaceutical products and radioactive materials; scientific research and development services in the fields of radiopharmacy, production, distribution, handling and analysis of chemical and pharmaceutical products and radioactive materials; design and development of medical technological devices; design and development of computer hardware for medical diagnostic apparatus and drug and fluid delivery apparatus for medical use; calibration services relating to medical equipment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TRASIS SA
- Other trademarks owned by TRASIS SA
- Other trademarks owned by TRASIS SA
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 037
- Other trademarks in Class 042
- Similar marks named TRASIS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 2, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 11, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 2, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 2, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 25, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 25, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 14, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 14, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 9, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 8, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 2, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 25, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 25, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 17, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 13, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 13, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 13, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 3, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 3, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 3, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 17, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 17, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 17, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 12, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 25, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 25, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 19, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 18, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 2, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 2, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 26, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |